Cortexyme Inc.

NASDAQ: CRTX · Real-Time Price · USD
1.95
0.05 (2.63%)
At close: Aug 01, 2022, 6:00 AM

Cortexyme Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a n/a n/a
Operating Income
-149.45M -154.97M -156.72M -87.63M -87.86M -84.35M
Interest Income
965K 980K 1.14M 812K 1.09M 1.59M
Pretax Income
-150.14M -155.05M -156.49M -87.1M -86.9M -82.76M
Net Income
-149.93M -155.12M -156.49M -87.1M -86.9M -82.76M
Selling & General & Admin
55.33M 53.33M 50.72M 26.19M 23.48M 20.6M
Research & Development
94.79M 102.31M 106.38M 61.44M 64.38M 63.75M
Other Expenses
n/a n/a n/a n/a n/a n/a
Operating Expenses
150.12M 155.64M 157.09M 87.63M 87.86M 84.35M
Interest Expense
662K 72K n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a
Cost & Expenses
150.12M 155.64M 157.09M 87.63M 87.86M 84.35M
Income Tax Expense
-95K 218K 373K 227K 256K 227K
Shares Outstanding (Basic)
32.47M 30.13M 29.77M 29.77M 29.59M 29.55M
Shares Outstanding (Diluted)
32.47M 30.13M 29.77M 29.77M 29.59M 29.55M
EPS (Basic)
-4.97 -5.21 -5.27 -2.95 -2.95 -2.81
EPS (Diluted)
-4.97 -5.21 -5.27 -2.95 -2.95 -2.81
EBITDA
-83.55M -89.07M -90.52M -87.81M -88.11M -84.59M
EBIT
-59.5M -65.03M -66.77M -66.77M -67.01M -63.5M
Depreciation & Amortization
295.06K 296K 344K 345K 342K 335K